Diseases, Conditions, Syndromes

FDA OKs second treatment for neuromyelitis optica spectrum disorder

(HealthDay)—Uplizna (inebilizumab-cdon) injection is now approved to treat neuromyelitis optica spectrum disorder (NMOSD) in patients who are anti-aquaporin-4 (AQP4) antibody positive, the U.S. Food and Drug Administration ...

Diseases, Conditions, Syndromes

Global study of ICU data to guide COVID-19 treatments

Queensland researchers are leading a worldwide clinical study using AI to examine COVID-19 patient data from 300 intensive care units (ICU) to provide insight for health professionals to determine the best treatments for ...

page 1 from 14